We work with partners in academia, health-care, industry and patient groups to help realize the potential of genomic medicine in neurological disorders. Our primary focus is amyotrophic lateral sclerosis, a devastating neurodegenerative disease that causes progressive paralysis, muscle wasting and death (lifetime risk ~ 1/350).
Our work integrates petabytes of data from global DNA sequencing efforts with experimental readouts from analyses of patient tissue and disease models (transcriptomics, epigenomics…).
We employ a wide variety of computational techniques, including our own adaptations of traditional bioinformatic methods and recent advances in AI / machine learning.
Necessary cookies are absolutely essential for the website to function properly. This category only includes cookies that ensures basic functionalities and security features of the website. These cookies do not store any personal information.
Any cookies that may not be particularly necessary for the website to function and is used specifically to collect user personal data via analytics, ads, other embedded contents are termed as non-necessary cookies. It is mandatory to procure user consent prior to running these cookies on your website.